Bluerock: Canada ’s stem cell contender on the journey from petri dish to clinical trial

Toronto-based regenerative medicine biotech BlueRock Therapeutics was launched in December with a massive $225m series A financing. So what stem cell-based therapies is the company working on?
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news